PATENT CLAIM ANALYSIS

Application Number: 15864156
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "190100"]

Abstract:
Provided are non-typeable  Haemophilus influenzae  vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the present application are also provided.

Claim (Index 40):
A pharmaceutical composition for the treatment of airways diseases, comprising an effective amount of killed non-typeable  Haemophilus influenzae , or an immunogenic outer membrane fraction or outer membrane protein component of the non-typeable  Haemophilus influenzae , the non-typeable  Haemophilus influenzae  comprising isolate NTHi-164 deposited with the National Measurement Institute (\u201cNMI\u201d) and assigned deposit no. V08/021002.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.34286
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13059185', '12531402', '14316935', '11096850', '11573889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6896569623639857
- 35 USC 102 Novelty (BERT): 0.6587004308696517
- Combined Prediction Score: 0.6865613092145523
- Mean Citation Score: 392.168242
- Max Citation Score: 666.25665
- Similarity Product: 595.3211855850934

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test